Litifilimab Antibody
Litifilimab (BIIB059) is a humanized monoclonal antibody that binds to BDCA2 (CLEC4C), a receptor on plasmacytoid dendritic cells. It is being investigated for the treatment of cutaneous lupus erythematosus, with research applications in both in vitro cellular assays and in vivo preclinical models of autoimmune disease.
Product Specifications
Product Name Alternative
Litifilimab, BIIB059, BIIB-059, BIIB 059
Target
Others
Conjugation
Unconjugated
Concentration
6.23 mg/mL
Purity
97.40% (May vary between batches)
Molecular Weight
145.23 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
15065154 3x 1.0 µg DNA
CASP14 CRISPR All-in-one AAV vector set (with saCas9)(Mouse)
Sign In for Pricing
View Details 
036441-HRP 200 µL
HAVCR1, NT (HAVCR1, KIM1, TIM1, TIMD1, Hepatitis A virus cellular receptor 1, Kidney injury molecule 1, T-cell immunoglobulin and mucin domain-containing protein 1, T-cell membrane protein 1, TIM-1) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details MBS1880029-01 0.01 mg
Human GP160 full length protein-synthetic nanodisc
Sign In for Pricing
View Details MBS1880029-02 0.05 mg
Human GP160 full length protein-synthetic nanodisc
Sign In for Pricing
View Details